NOTE TO THE FILE
SERIAL NUMBER: 87427972
DATE: 10/03/2017
NAME: kdindayal
NOTE:
Searched: Discussed ID with:
Google Senior Atty
Lexis/Nexis Managing Atty
OneLook
Wikipedia
Acronym Finder Protest evidence reviewed
Other:Checked: Discussed Geo. Sig. with:
Geographic significance Senior Atty
Surname Managing Atty
Translation
ID with ID/CLASS mailboxChecked list of approved Canadian attorneys and agents
Discussed file with
Attorney/Applicant via:
phone Left message with
email Attorney/ApplicantRequested Law Library search Issued Examiner’s Amendment
for: and entered changes in TRADEUPSPRINT DO NOT PRINT Added design code in TRADEUPS
Description of the mark
Translation statement Re-imaged standard character
drawing
Negative translation statement
Consent of living individual Contacted TM MADRID ID/CLASS
about misclassified definite ID
Changed TRADEUPS to:X OTHER:
From: Leahy, Brandon [mailto:bleahy@wsgr.com]
Sent: Monday, October 02, 2017 1:58 PM
To: Dindayal, Karen <Karen.Dindayal@USPTO.GOV>
Cc: Kahn, Cecilia <ckahn@wsgr.com>; Trademarks <Trademarks@wsgr.com>
Subject: Office Action - Serial Number 8742792
Ms. Dindayal,
I am the correspondent attorney for the trademark application for the mark FUSE (Ser. No. 87427972). Can you please issue an examiner’s amendment, adopting the revised identifications of services language proposed in your Office Action dated July 31?
Specifically, please revise to:
Class 41: conducting fellowship training services, namely, training fellows with governmental bodies and agencies in the fields of various leadership practices, improving government services, project management, community engagement, human-centered design and rapid innovation techniques
Please confirm. If needed, I may be reached at the number below.
Thank you,
Brandon Leahy
Brandon P. Leahy
Wilson Sonsini Goodrich & Rosati, P.C.
650 Page Mill Road | Palo Alto, CA 94304
Direct: 650.849.3204
This email and any attachments thereto may contain private, confidential, and privileged material for the sole use of the intended recipient. Any review, copying, or distribution of this email (or any attachments thereto) by others is strictly prohibited. If you are not the intended recipient, please contact the sender immediately and permanently delete the original and any copies of this email and any attachments there